Manlaran, Shimmer Jane I.
HRN: 20-96-07 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2025
CEFUROXIME 750MG (VIAL)
11/19/2025
11/26/2025
IV
750mg
Q8h
UTI
Checking Initial Appropriateness
11/19/2025
CEFUROXIME 750MG (VIAL)
11/19/2025
11/25/2025
IV
750 Mg
Q8
Urinary Tract Infection
Checking Initial Appropriateness